Wednesday's hot stocks: AMD, KO, X >>> READ MORE
Barry Cohen
Barry Cohen (RSS)
Health Care Writer

Barry Cohen has nearly 30 years in communications and marketing, the majority in senior positions at three large international health care companies – Abbott Laboratories, Warner-Lambert (now part of Pfizer) and Bayer, Inc.

Read complete bio
Recent Articles

Merck Is Shopping for Smarts In Hep C

Jan. 13, 2012, 7:30 am EDT – The pharma giant says it's determined to be the leader in treatments for the disease -- a market that is expected to hit $20 billion by 2020. More 

Idenix and Achillion Jump on Takeover Talk

Jan. 10, 2012, 12:28 pm EDT – Their hepatitis C drugs could be lures for Big Pharma after a rival gets a juicy offer from Bristol-Myers Squibb. More 

Why Disposing of Stericycle Shares May Be Right Move

Jan. 10, 2012, 6:00 am EDT – Despite dropping by more than 10% since October, Stericycle shares still have more room below it. But the company does have a few options to reassure investors. More 

Dendreon Jumps 40% on Provenge Sales

Jan. 5, 2012, 3:51 pm EDT – Dendreon saw its stock jump Thursday as sales of its cancer drug beat the expectations of both analysts and the company itself. More 

Teva’s New CEO Is Battle-Tested. Good Thing

Jan. 4, 2012, 2:06 pm EDT – Drug industry vet Jeremy Levin earned his stripes making deals for Bristol-Myers Squibb, but he'll face tough going at the generic-drug maker. More 

Mead Johnson Bounce Followed J&J Script

Jan. 4, 2012, 9:40 am EDT – Mead Johnson's recent Enfamil scare sent many investors packing -- but those who stuck with the stock could soon be rewarded. More 

FDA, Insurers Demand Tests for New Drugs

Jan. 3, 2012, 11:51 am EDT – Pressure on pharmaceutical companies for evidence that their drugs work is fueling a surge in the global market for "companion diagnostics." More 

2011’s Best and Worst Picks From InvestorPlace’s Barry Cohen

Dec. 28, 2011, 10:59 am EDT – Barry Cohen discusses some of his picks from 2011 -- and how that will affect his take on companies moving forward. More 

Walgreen Not Sweating Loss of Express Scripts Customers to CVS — Should It Be?

Dec. 22, 2011, 8:40 am EDT – CVS says it could gobble up to 23M prescriptions that Walgreens has sold through Express Scripts if a deal isn't announced. So far, WAG is sticking to its guns. More 

Ariad Pharmaceuticals Still Might Have Upside

Dec. 21, 2011, 12:34 pm EDT – Ariad Pharmaceuticals is up 120% in the past 12 months, mostly fueled on optimism over its trial leukemia treatment. But some analysts think the ceiling is higher. More